U.S. President Donald Trump indicated on 29 October 2025 that his administration may reduce tariffs on Chinese goods that relate to fentanyl precursor chemicals, contingent on Beijing strengthening controls over supply chains. The announcement comes ahead of his meeting with Chinese counterpart Xi Jinping at the APEC Economic Leaders’ Meeting and follows recent U.S. efforts to tie trade policy with public-health outcomes. Trade specialists say such linkage could open a new front in trade diplomacy but also introduce more volatility into traditional tariff-strategies.